Leading With Care: Update on HIV Programming 5/16/25
Over the last few months, while faced with unprecedented challenges, continuity of care for our patients living with HIV and the most vulnerable Kenyans has been our primary concern.
We are grateful for you, our community of supporters, and your generous contributions to the AMPATH Kenya Emergency Response Fund which enabled us to continue to care for people while funding was paused or inaccessible.
The President’s Emergency Plan for AIDS Relief (PEPFAR), administered by USAID, is a tremendous success story of how we can work together to solve tough problems. Currently, 127,000+ people living with HIV in Kenya receive care from AMPATH partners through PEPFAR.
AMPATH research efforts are largely supported by the U.S. National Institutes of Health (NIH) with funding to both Kenyan and U.S. partners. Most of these grants are “implementation science” which is designed to find new and better ways to provide care by working with real patients who voluntarily participate in research studies.
The funding situation continues to evolve and new challenges are now impacting some care and research initiatives. Here is what we know:
Most AMPATH HIV care and treatment programs funded through PEPFAR have resumed. Patients are able to access care as per usual.
Recently announced changes by NIH to global health research grants will impact 29 projects prior to September 30th. This will pause or eliminate many programs that seek ways to understand diseases processes, prevent disease, improve healthcare delivery, and optimize treatment of specific diseases (e.g. tuberculosis, HIV and malaria). These changes will impede scientific discovery, adversely impact care, and substantially slow the development of human resources for health in Kenya.
AMPATH leaders are working to identify the most critical unmet needs and to design and implement solutions that keep care available. This includes developing models that integrate HIV care into Government of Kenya-supported primary care and chronic disease care structures.
Philanthropic support provides critical and immediate funds to extend care, research and workforce efforts and to prepare for future anticipated needs.
A targeted goal of $5 million in 2025 will fuel efforts to redesign research and care delivery. Your investment will aid in this effort, and you will help fill funding gaps for parts of the program for which funding has not been received or not expected to receive continued support from the U.S. Government.
Thank you for your support of AMPATH Kenya as we hold fast to our commitment to care for those who need us most.
Read more about the people and programs that are part of AMPATH’s successful HIV care and treatment program made possible by support from the American People through PEPFAR and USAID:
